Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linagliptin Inpatient Trial
NCT02004366Phase 4Completed
- Sponsor
- Emory University
- Start
- Jan 2014
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of linagliptin in type 2 diabetes mellitus (T2DM), sponsored by Emory University. Started Jan 2014; status: completed.
02
Drugs
linagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT02004366.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02004366.